HepQuant develops non-invasive, quantitative tests that measure liver health. The HepQuant DuO Test enables healthcare providers to manage patients with liver diseases more effectively. The HepQuant DuO Test delivers information about liver cell function and portal-systemic shunting, attributes of liver disease that are associated with clinical outcomes. Results may be used by a physician in conjunction with clinical evaluation and other tests to aid in the decision to proceed with or defer invasive procedures, to monitor treatment response, or to predict disease progression and adverse outcomes, such as ascites, encephalopathy and variceal bleeding.
| Website | https://www.hepquant.com |
| Revenue | $2 million |
| Employees | 27 (23 on RocketReach) |
| Founded | 2007 |
| Address | 8110 E. Union Ave Suite 750, Denver, Colorado 80219, US |
| Phone | (303) 923-2242 |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Medical and Diagnostic Laboratories, Business Services General, Business Services |
| Competitors | bioMérieux, Roche, Thermo Fisher Scientific, Siemens, AbbVie, PerkinElmer, Inc., Labcorp, Abbott, Quest Diagnostics, GSK +44 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular HepQuant employee's phone or email?
The HepQuant annual revenue was $2 million in 2026.
Joellyn Enos is the Chief Commercial Officer (CCO) of HepQuant.
23 people are employed at HepQuant.
HepQuant is based in Denver, Colorado.
The NAICS codes for HepQuant are [541714, 541, 5417, 54171, 54].
The SIC codes for HepQuant are [873, 87].